Section of Protein Structure and Function, Laboratory of Retinal Cell and Molecular Biology, NEI-NIH, Bethesda, MD, USA.
Int J Oncol. 2012 Jul;41(1):219-27. doi: 10.3892/ijo.2012.1431. Epub 2012 Apr 10.
Recently, we have shown that the antiangiogenic pigment epithelium-derived factor (PEDF) can bind the catalytic β-subunit of F1-ATP synthase and inhibit endothelial cell surface ATP synthase activity. This factor can additionally restrict tumor growth, invasion and metastasis, and can directly induce death on several tumor cell types. Active cell surface ATP synthase is also present in certain tumor cells and its ATP product is considered a stimulus for tumor growth. The present study aimed to elucidate the biological implications of the interactions between the extracellular PEDF and tumor cell surface ATP synthase. Incubation of T24 human urinary bladder carcinoma cells in media containing human recombinant PEDF protein for 48-96 h dramatically decreased cell viability in a concentration-dependent fashion as monitored by real-time cell impedance with a microelectronic system, microscopic imaging and biomarkers of live cells. Intact tumor cells exhibited cell surface ATP synthesis activity, which was inhibited by piceatannol, a specific inhibitor of F1/F0-ATP synthase. Immunoblotting revealed that the β subunit of F1-ATP synthase was present in plasma membrane fractions of these cells. Interestingly, pre-incubation of tumor cells with PEDF inhibited the activity of cell surface ATP synthase in a concentration-dependent fashion. The PEDF-derived peptide 34-mer decreased tumor cell viability and inhibited extracellular ATP synthesis to the same extent as full-length PEDF. Moreover, ATP additions attenuated both the PEDF-mediated decrease in tumor cell viability and the inhibition of endothelial cell tube formation. The results lead to conclude that PEDF is a novel inhibitor of tumor cell surface ATP synthase activity that exhibits a cytotoxic effect on tumor cells, and that the structural determinants for these properties are within the peptide region 34-mer of the PEDF polypeptide. The data strongly suggest a role for the interaction between the 34-mer region of PEDF and tumor cell-surface ATP synthase in promoting tumor cell death.
最近,我们已经表明,抗血管生成的色素上皮衍生因子(PEDF)可以与 F1-ATP 合酶的催化β亚基结合,并抑制内皮细胞表面的 ATP 合酶活性。这种因子还可以限制肿瘤的生长、侵袭和转移,并可以直接诱导几种肿瘤细胞类型的死亡。活性细胞表面的 ATP 合酶也存在于某些肿瘤细胞中,其 ATP 产物被认为是肿瘤生长的刺激物。本研究旨在阐明细胞外 PEDF 与肿瘤细胞表面 ATP 合酶之间相互作用的生物学意义。用含重组人 PEDF 蛋白的培养基孵育 T24 人膀胱癌细胞 48-96 小时,用微电子系统实时细胞阻抗、显微镜成像和活细胞标志物监测,浓度依赖性地显著降低细胞活力。完整的肿瘤细胞表现出细胞表面 ATP 合成活性,这种活性被 F1/F0-ATP 合酶的特异性抑制剂 piceatannol 抑制。免疫印迹显示 F1-ATP 合酶的β亚基存在于这些细胞的质膜部分。有趣的是,PEDF 预处理以浓度依赖的方式抑制肿瘤细胞表面 ATP 合酶的活性。PEDF 衍生的 34 肽降低肿瘤细胞活力,并抑制细胞外 ATP 合成,其程度与全长 PEDF 相同。此外,ATP 的添加减弱了 PEDF 介导的肿瘤细胞活力下降和内皮细胞管形成的抑制。结果表明,PEDF 是一种新型的肿瘤细胞表面 ATP 合酶活性抑制剂,对肿瘤细胞具有细胞毒性作用,而这些特性的结构决定因素位于 PEDF 多肽的 34 肽区域内。数据强烈表明,PEDF 的 34 肽区域与肿瘤细胞表面 ATP 合酶之间的相互作用在促进肿瘤细胞死亡中起作用。